Prioritisation of COVID-19 boosters in the omicron era.

Irving, Stephanie A; Sundaram, Maria E

Irving, Stephanie A; Sundaram, Maria E.

Irving SA; Kaiser Permanente Center for Health Research, Portland, OR 97227, USA. Electronic address: stephanie.a.irving@kpchr.org.
Sundaram ME; Center for Clinical Epidemiology and Population Health, Marshfield Clinic, Marshfield WI, USA.

Lancet ; 400(10360): 1282-1283, 2022 10 15.

Article en En | MEDLINE | ID: mdl-36244366

Asunto(s)

COVID-19; Humanos; Inmunización Secundaria

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560778
https://dx.doi.org/10.1016/S0140-6736(22)01971-7

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560778
https://dx.doi.org/10.1016/S0140-6736(22)01971-7

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article